Product Information

TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3547 per EA under NDC 68462084213. Its NADAC has been published 256 times since Sep 29, 2021.

FDA first approved this application on Mar 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB

Telmisartan and Hydrochlorothiazide
$0.3547per EA

Strength

25; 80 mg/1; mg/1

NDC

68462084213

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202544

FDA Approved

3/4/2019

TE Code

AB

On Market Since

3/4/2019

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB has been published 256 times since Sep 29, 2021, and over the history we have for it it has declined 79.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3547 per EA
All-time high$1.7441 (Dec 15, 2021)
All-time low$0.3536 (Jun 17, 2026)
52-week high$0.4511
52-week low$0.3536
Median price$0.5994
Average price$0.7328
Largest weekly change+54.6% (Feb 22, 2023)
Weeks tracked256
Tracking sinceSep 29, 2021

Price History

1W

+0.3%

1M

+0.3%

3M

-2.0%

6M

-6.6%

1Y

-21.4%

3Y

-40.9%

5Y

N/A

All

-79.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3547 per EA (NDC 68462084213), effective Aug 19, 2026.

How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB changed over time?

Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB has declined 79.7%. It has been tracked across 256 weekly CMS publications since Sep 29, 2021.

What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB?

Since Sep 29, 2021, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB has ranged from a low of $0.3536 (Jun 17, 2026) to a high of $1.7441 (Dec 15, 2021), with a median of $0.5994 per EA.

Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB?

TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB (NDC 68462084213) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.